CarelonRx — Operating expense
Elevance Health CarelonRx — Operating expense decreased by 14.5% to $188.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 18.3%, from $230.00M to $188.00M. Over 3 years (FY 2022 to FY 2025), CarelonRx — Operating expense shows an upward trend with a 99.5% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
Increasing expenses may indicate investment in new technology or infrastructure, while excessive growth relative to revenue could signal operational inefficiencies.
Detailed definition
The administrative and operational costs required to run the CarelonRx segment, excluding direct benefit and product cos...
Peer comparison
Comparable to Selling, General, and Administrative (SG&A) expenses for specialized healthcare service segments.
elv_segment_carelonrx_operating_expenseHistorical Data
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $28.50M | $28.50M | $28.50M | $28.50M | $68.00M | $68.00M | $68.00M | $68.00M | $171.00M | $237.00M | $188.00M | $215.00M | $230.00M | $223.00M | $232.00M | $220.00M | $188.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +138.6% | +0.0% | +0.0% | +0.0% | +151.5% | +38.6% | -20.7% | +14.4% | +7.0% | -3.0% | +4.0% | -5.2% | -14.5% |
| YoY Change | — | — | — | — | +138.6% | +138.6% | +138.6% | +138.6% | +151.5% | +248.5% | +176.5% | +216.2% | +34.5% | -5.9% | +23.4% | +2.3% | -18.3% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Elevance Health's carelonrx — operating expense?
- Elevance Health (ELV) reported carelonrx — operating expense of $188.00M in Q1 2026.
- How has Elevance Health's carelonrx — operating expense changed year-over-year?
- Elevance Health's carelonrx — operating expense decreased by 18.3% year-over-year, from $230.00M to $188.00M.
- What is the long-term trend for Elevance Health's carelonrx — operating expense?
- Over 3 years (2022 to 2025), Elevance Health's carelonrx — operating expense has grown at a 99.5% compound annual growth rate (CAGR), from $114.00M to $905.00M.
- What does carelonrx — operating expense mean?
- The overhead and administrative costs required to operate the pharmacy services business.